FDA Finalizes Guidelines To Keep Cancerous Impurities Out of U.S. Medications
Nitrosamine contamination has resulted in massive recalls for valsartan, Zantac and other medications, as well as lawsuits by users who developed cancer.
Tag Archives: Drug Recalls
-
-
Pentagon Asks Valisure, Not FDA, to Make Sure Drugs for Servicemembers are Safe
The Defense Department is reportedly seeking Valisure's help in ensuring generic drugs, often manufactured overseas and away from FDA influence, given to military service members are safe and effective
-
Plans to Remove Potentially Carcinogenic Contaminants from Januvia, Janumet Outlined By Merck
Merck indicates it has identified the cause of nitrosamine contaminants in some batches of Januvia and Janumet, which occurs during the manufacturing and storage process.
-
FDA Inspectors Say Valisure’s Former Pharmacy Division Failed to Meet Drug Security Requirements
Inspectors say Valisure appeared to be unfamiliar with key portions of the Food, Drug and Cosmetic Act linked to drug supply chain security.
-
FDA Issues New Guidance To Prevent Drug Contamination By NDMA, Similar Toxic Chemicals
-
Congress Urged To Require Independent Testing Of All Foreign Drugs, After Finding NDMA In Zantac, Metformin
-
FDA Calls for Metformin Recalls By Five Manufacturers, Due To NDMA Contamination That May Increase Cancer Risk
-
Losartan Wrongful Death Lawsuit Filed By Family of Woman Diagnosed With Liver Cancer
-
Metformin Recall Urged Due To Presence of Cancer-Causing NDMA
-
Metformin NDMA Levels Undetectable or Lower Than Federal Limits: FDA
